COGT

Cogent Biosciences Inc

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Cogent Biosciences Inc Stock Price

Vitals

Today's Low:
$12.1100
Today's High:
$12.8900
Open Price:
$12.7800
52W Low:
$3.79
52W High:
$18.07
Prev. Close:
$12.8200
Volume:
918138

Company Statistics

Market Cap.:
$0.798 billion
Book Value:
3.774
Revenue TTM:
$0.000 billion
Operating Margin TTM:
0%
Gross Profit TTM:
$-0.056 billion
Gross Profit TTM:
$-0.056 billion
Profit Margin:
0%
Return on Assets TTM:
-23.7%
Return on Equity TTM:
-41.2%

Company Profile

Cogent Biosciences Inc had its IPO on 2018-03-29 under the ticker symbol COGT.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Cogent Biosciences Inc has a staff strength of 0 employees.

Stock update

Shares of Cogent Biosciences Inc opened at $12.78 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $12.11 - $12.89, and closed at $12.14.

This is a -5.3% slip from the previous day's closing price.

A total volume of 918,138 shares were traded at the close of the day’s session.

In the last one week, shares of Cogent Biosciences Inc have slipped by -6.62%.

Cogent Biosciences Inc's Key Ratios

Cogent Biosciences Inc has a market cap of $0.798 billion, indicating a price to book ratio of 3.726 and a price to sales ratio of 1320.63.

In the last 12-months Cogent Biosciences Inc’s revenue was $0.000 billion with a gross profit of $-0.056 billion and an EBITDA of $-0.112 billion. The EBITDA ratio measures Cogent Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cogent Biosciences Inc’s operating margin was 0% while its return on assets stood at -23.7% with a return of equity of -41.2%.

In Q2, Cogent Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.

Cogent Biosciences Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-2.208 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cogent Biosciences Inc’s profitability.

Cogent Biosciences Inc stock is trading at a EV to sales ratio of 925.41 and a EV to EBITDA ratio of -6.21. Its price to sales ratio in the trailing 12-months stood at 1320.63.

Cogent Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Cogent Biosciences Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Cogent Biosciences Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Cogent Biosciences Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Cogent Biosciences Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Cogent Biosciences Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$12.14
52-Week High
$18.07
52-Week Low
$3.79
Analyst Target Price
$23

Cogent Biosciences Inc stock is currently trading at $12.14 per share. It touched a 52-week high of $18.07 and a 52-week low of $18.07. Analysts tracking the stock have a 12-month average target price of $23.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Cogent Biosciences Inc

The stock symbol (also called stock or share ticker) of Cogent Biosciences Inc is COGT

The IPO of Cogent Biosciences Inc took place on 2018-03-29

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$1.88
-0.19
-9.18%
$5.52
-0.28
-4.83%
$1.73
0
0%
$11.31
-0.1
-0.88%
$2.02
-0.2
-9.01%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge, Massachusetts.

Address

200 CAMBRIDGE PARK DRIVE, SUITE 3100, CAMBRIDGE, MA, US